C002

אקס טי אל ביופרמסוטיקלס בע"מ

Public

X T L BIOPHARMACEUTICALS LTD

Corporation no: 520039470

Stock Exchange/Market: אקס טי אל

Hasapir 3 , Nes Ziona 76100 , ,

Tel: 08-9304444 , Fax: 08-9304445

E.mail address: rcohen@xtlbio.com

Date of transmission: 08/02/2009

Reference: 2009-02-031611


Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il


Amended report for distorted report sent on date : 05/02/2009 , Whose reference number was: 2009-02-031347
The distortion: An extra resolution in the first EGM.
The distortion cause: A mistake
The main amendment: The extra resolution was removed, all other resolutions- updated accordingly

Immediate Report

Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on an updated press release- Company's Extra Ordinary Meetings

XTL_EGM_PR_05-02-09_FINAL_UPDATED_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):

Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD

Date of revision of form structure: 31/12/2008

Name of the Signatory: : Kantor Ronen , Position of Signatory in the reporting corporation: Legal Consultant & Corporate Secretary , Name of Employer Company: .

Abba Hillel Silver Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com